Klarnachrichten

Drug companies close sites in Germany

196

The company Biontech closes many sites. It affects the cities Idar-Oberstein, Marburg and Tuebingen. A site in Singapore closes too. Up to 1,860 people lose their job. Biontech makes no more corona vaccines there. The partner Pfizer does this alone now. Biontech lost much money lately. The company wants to save 500 million Euro now. The money goes into research against cancer. The sites close until the year 2027. The mayor of Tuebingen thinks this is bad. He wants solutions for the workers.

The company Novartis also closes a site. It stands in the city Wehr. 220 people work there. They make pills and capsules. The site is not modern enough anymore. It closes until the end of 2028. Novartis builds a new site in Halle instead. There, people make medicine against cancer. Novartis pays 35 million Euro for this. 2,600 people work for Novartis in Germany.

The union IG BCE is angry at Biontech. It says: The company thinks only of money. The workers feel alone. But Biontech wants new drugs against cancer until 2030. The founders of Biontech leave too. Ugur Sahin and Oezlem Tuereci found a new company. They want to do new research there.

This text was generated automatically and has not been reviewed for accuracy. No guarantee is given for the correctness of the content. Learn more Learn more about article generation

Definitions

mRNA-Technology
A modern way to make vaccines and medicine. It uses body information.
Oncology
A part of medicine. It deals with cancer.
Social plan
An agreement between boss and workers at job losses. It helps the workers.

People

Ugur Sahin
Scientist and founder of Biontech.
Oezlem Tuereci
Scientist and founder of Biontech.
Boris Palmer
Mayor of the city Tuebingen.

Locations

Tuebingen
A city in Germany.
Marburg
A city in Germany.
Wehr
A city in Germany.
Idar-Oberstein
A city in Germany.

Sources

Logo Schweizer Radio und Fernsehen (SRF)
Schweizer Radio und Fernsehen (SRF)

Novartis schliesst Werk in Deutschland – 220 Stellen betroffen

Read now
Logo DIE ZEIT
DIE ZEIT

Pharma: Biontech schließt Standorte – gut 800 Curevac-Jobs betroffen

Read now
Logo DIE ZEIT
DIE ZEIT

Pharma: Kritik an Curevac-Aus in Tübingen – Palmer fordert Lösungen

Read now
Logo Kurier
Kurier

Ende der Corona-Ära: Biontech gibt Impfstoffproduktion auf

Read now
Logo DIE ZEIT
DIE ZEIT

Pharma: Nach Übernahme: Rund 820 frühere Curevac-Jobs in Gefahr

Read now
Logo FAZ.NET
FAZ.NET

1860 Stellen betroffen: Biontech stellt deutsche Corona-Impfstoffproduktion ein

Read now
Logo DIE ZEIT
DIE ZEIT

Pharma: Biontech schließt auch Marburger Werk – 540 Jobs betroffen

Read now
Logo stern.de
stern.de

Biontech schließt auch Marburger Werk – 540 Jobs betroffen

Read now
Logo FAZ.NET
FAZ.NET

Ende der Corona-Impfstoff-Produktion: Biontech streicht fast 2000 Stellen

Read now